Disease-burden-adapted immunotherapy protocol for primary refractory or high-risk relapsed pediatric acute lymphoblastic leukemia
Hemasphere
.
2024 Jul 29;8(8):e111.
doi: 10.1002/hem3.111.
eCollection 2024 Aug.
Authors
Sanaa Khan
1
,
Krishnan Vp
2
,
Yamini Krishnan
2
,
Gazel Sainulabdin
2
,
Somdipa Pal
2
,
Rincy Mathews
2
,
Darshan Kataria
1
,
Kunal Sehgal
3
,
Purva Kanvinde
4
,
Lashkari Harshaprasad
5
,
Minnie Bodhanwala
6
,
Bharat Agarwal
1
,
Ambreen Pandrowala
1
,
Prashant Hiwarkar
1
Affiliations
1
Department of Blood and Marrow Transplant Bai Jerbai Wadia Hospital for Children Mumbai India.
2
Department of Pediatric Hematology, Oncology and Bone Marrow Transplantation MVR Cancer Centre Kozhikode India.
3
Sehgal Path Lab Mumbai India.
4
Department of Pediatric Haematology-Oncology Bai Jerbai Wadia Hospital for Children Mumbai India.
5
Department of Paediatric Haematology-Oncology Kasturba Medical College Mangalore India.
6
Department of Pediatrics Bai Jerbai Wadia Hospital for Children Mumbai USA.
PMID:
39081802
PMCID:
PMC11284769
DOI:
10.1002/hem3.111
No abstract available